Monday , May 20 2019
Home / Financial News / FSD Pharma makes acquisition and receives Cannabis sales license from Health Canada

FSD Pharma makes acquisition and receives Cannabis sales license from Health Canada

FSD Pharma (CSE:HUGE-OTCQB:FSDDF) Executive Co-Chairman and CEO Dr Raza Bokhari sat down with Steve Darling from Proactive Investors Vancouver to talk about FSD hitting a company milestone by receiving their cannabis sales license from Health Canada.

Dr Bokhari also told Proactive about their recent acquisition of Prismic Pharmaceuticals. That company is a US-based speciality R&D pharmaceutical company that is developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilizing micro-palmitoylethanolamide’s “entourage” effect on certain drugs impacting the endocannabinoid system.

SOURCE: FSD Pharma

 

About Investment Value Finders

Check Also

World Class Extractions to service pot growers

World Class Extractions to service pot growers

As the legal cannabis consumption trend continues to gain steam, most of the sector participants …